Seeking Alpha

  Nektar Therapeutics - NASDAQ

10/31/2014, 11:42 AM ET
  • Jim Van Meerten | Send Message 28 Sep 2012

    NKTR - 96% Barchart technical buy signal - 15 new highs and up 26.27% in the last month - Relative strength Index 77.91%
      NKTR vs. ETF Alternatives
      Company Description
      Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States